Tsai, Max
Nery, Emel Serap Monkul
Kerr, Lisa
Khanna, Rashna
Komori, Mika
Dennehy, Ellen B.
Wilbraham, Darren
Winner, Paul
Funding for this research was provided by:
Eli Lilly and Company
Article History
Accepted: 5 November 2020
First Online: 10 February 2021
Declarations
:
: This study was sponsored by Eli Lilly and Company.
: Max Tsai, Emel Serap Monkul Nery, Lisa Kerr, Rashna Khanna, Mika Komori, Ellen B. Dennehy, and Darren Wilbraham are employees and minor stock holders of Eli Lilly and Company. Paul Winner has received research grants, an honorarium, and travel reimbursements from Eli Lilly and Company.
: All clinical studies described herein have been approved by the appropriate Ethics Committees of all participating centers and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: In this study, a legal representative had to sign a statement of informed consent for a child to participate in the study. In addition to informed consent given by the legal representative, the child may have been required to give documented assent, if capable.
: Not applicable.
: The datasets generated and/or analyzed during the current study are not publicly available because participants of this study did not agree for their data to be shared publicly.
: Not applicable.
: All authors participated in the interpretation of the study results and in the drafting, critical revision, and approval of the final version of the manuscript. MT, ESMN, LK, RK, MK, EBD, and DW were involved in the study design, data collection, and data analyses. MT, EBD, RK, MK, and PW were responsible for study monitoring, and MT and LK were responsible for data analysis and plotting.